dc.contributor.author | Ekici, Yeliz | |
dc.contributor.author | Yilmaz, Abdullah | |
dc.contributor.author | Kucuksezer, Umut Can | |
dc.contributor.author | Gazioglu, Sema Bilgic | |
dc.contributor.author | Yamalioglu, Zeynep Dogusan | |
dc.contributor.author | Gurol, Ali Osman | |
dc.contributor.author | Linn, Thomas | |
dc.contributor.author | Tuncer, Feyza Nur | |
dc.date.accessioned | 2021-12-21T08:46:52Z | |
dc.date.available | 2021-12-21T08:46:52Z | |
dc.date.issued | 2021 | |
dc.identifier.issn | 1357-0560 | |
dc.identifier.issn | 1559-131X | |
dc.identifier.uri | https://doi.org/10.1007/s12032-021-01560-4 | |
dc.identifier.uri | http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/2115 | |
dc.description.abstract | Pancreatic ductal adenocarcinoma (PDAC) is among the most deadly cancers. Since most patients develop resistance to conventional treatments, new approaches are in urgency. Valproic acid (VPA) was shown to induce apoptosis and reduce proliferation in PANC- | |
dc.description.sponsorship | Scientific Research Projects Coordination Unit of Istanbul UniversityIstanbul University [32763] | |
dc.language.iso | English | |
dc.publisher | Humana Press Inc | |
dc.title | Combined evaluation of proliferation and apoptosis to calculate IC50 of VPA-induced PANC-1 cells and assessing its effect on the Wnt signaling pathway | |
dc.type | Article | |
dc.relation.journal | Medıcal Oncology | |
dc.identifier.issue | 9 | |
dc.identifier.volume | 38 | |
dc.identifier.doi | 10.1007/s12032-021-01560-4 | |
dc.relation.issue | 9 | |
dc.relation.volume | 38 | |